First time ultra-sensitive and simultaneous quantification of proteins, interactions, and post-translational modifications in single cells to enable exponential growth in proteomics and interactomics

PICO-NGS aims to revolutionize proteomics by enabling ultra-sensitive, high-parallel measurement of proteins, interactions, and modifications, accelerating advancements in various industries.

Subsidie
€ 2.498.125
2023

Projectdetails

Introduction

In a human cell, there are about 20k protein coding genes (genome) that originate ~100k proteins (proteome). Proteins are involved in complex networks of protein-protein interactions (PPIs) influenced by post-translational modifications (PTMs), the interactome of living cells (~800,000 entities).

Genome and Proteome

The genome is mostly static throughout the cell's lifetime and can be sequenced today in less than 1 hour. The proteome and interactome are changing with factors such as environment and health, and they are not yet fully known.

Current Challenges

Today's methods for proteomics and interactomics are tedious and lack:

  • Sensitivity
  • Quantitativity
  • Parallelism

PICO-NGS Solution

PICO-NGS combines ultra-high sensitivity (>10 fM) with high parallelism, measuring proteins, PPIs, and PTMs simultaneously (>50 targets).

Market Impact

This innovation will disrupt the global proteomics market, which is valued at 29 billion USD with a 16% CAGR.

Future Applications

PICO-NGS will fertilize groundbreaking academic research and accelerate developments in various industries, including:

  1. Pharma (drug discovery)
  2. Biotech (biomarkers/diagnosis)
  3. Agrotech (crop sciences)

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.498.125
Totale projectbegroting€ 3.568.750

Tijdlijn

Startdatum1-8-2023
Einddatum31-7-2025
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • ACTOME GMBHpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen EIC Accelerator

EIC Accelerator

The ProM platform: New ways to drug the undruggable

PROSION's ProM-platform aims to unlock and target the undruggable 85% of the human proteome, developing new therapies for hard-to-treat diseases like cancer.

€ 2.461.375

Vergelijkbare projecten uit andere regelingen

Mkb-innovati...

Haalbaarheidsonderzoek: portable nanopore device voor de identificatie van eiwitten en biomarkers.

Portal Biotech ontwikkelt een draagbaar analysetoestel op basis van nanopore technologie om real-time eiwitmetingen mogelijk te maken, wat de diagnostiek revolutionair verandert.

€ 20.000
Mkb-innovati...

Haalbaarheidsonderzoek analyse-apparaat voor volledige en gevouwen eiwitten

Portal Biotech ontwikkelt een innovatieve nanopore-technologie voor het meten van volledige eiwitten, met als doel de diagnostiek te revolutioneren en klinische beslissingen te verbeteren.

€ 20.000
Mkb-innovati...

Functional Cell Sorter

Dit project richt zich op het karakteriseren en sorteren van individuele cellen op functie om moleculaire eigenschappen te koppelen, wat de ontwikkeling van medicijnen en ziekteonderzoek bevordert.

€ 185.500
ERC Starting...

Single-Molecule Acousto-Photonic Nanofluidics

SIMPHONICS aims to develop a high-throughput, non-invasive platform for protein fingerprinting by integrating nanopore technology with acoustic manipulation and fluorescence detection.

€ 1.499.395
ERC Starting...

Learning Isoform Fingerprints to Discover the Molecular Diversity of Life

This project aims to revolutionize proteomics by developing a novel data analysis strategy using deep learning to discover and quantify protein isoforms through their unique multi-dimensional fingerprints (ORIGINs).

€ 1.498.939